Haemonetics Anticoagulant Sodium Citrate and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Haemonetics Anticoagulant Sodium Citrate and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium citrate
Brand name:
Synonyms: Anticoagulant Sodium Citrate
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Haemonetics Anticoagulant Sodium Citrate-Insulin degludec
- Haemonetics Anticoagulant Sodium Citrate-Insulin Degludec (U-100) Prefilled Pens
- Haemonetics Anticoagulant Sodium Citrate-Insulin Degludec (U-100) Vials
- Haemonetics Anticoagulant Sodium Citrate-Insulin Degludec (U-200) Prefilled Pens
- Haemonetics Anticoagulant Sodium Citrate-Insulin degludec and liraglutide
- Haemonetics Anticoagulant Sodium Citrate-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Haemophilus b conjugate (PRP-OMP) vaccine
- Insulin aspart, recombinant Subcutaneous-Haemophilus b conjugate (PRP-T) vaccine
- Insulin aspart, recombinant Subcutaneous-Haemophilus b conjugate and hepatitis b vaccine Intramuscular
- Insulin aspart, recombinant Subcutaneous-Haemophilus b Conjugate Vaccine
- Insulin aspart, recombinant Subcutaneous-Haemophilus b conjugate vaccine Intramuscular
- Insulin aspart, recombinant Subcutaneous-Hailey 1.5/30